| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.15 | 4e-05 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0008 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.15 | 0.004 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | 0.099 | 0.004 |